Allspring Global Investments
RGNX icon

Allspring Global Investments’s Regenxbio RGNX Stock Holding History

Allspring Global Investments’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-325
Closed -$3.8K – 2566
2024
Q2 		$3.8K Sell
325
-2,353
-88% -$36.6K ﹤0.01% 2248
2024
Q1 		$56.4K Buy
+2,678
New +$47.7K ﹤0.01% 1933
2023
Q4 		– Sell
-3,195
Closed -$52.6K – 2645
2023
Q3 		$52.6K Sell
3,195
-3,769
-54% -$68.3K ﹤0.01% 2250
2023
Q2 		$139K Sell
6,964
-7,786
-53% -$150K ﹤0.01% 1937
2023
Q1 		$279K Buy
14,750
+1,975
+15% +$43.7K ﹤0.01% 1741
2022
Q4 		$290K Buy
12,775
+5,164
+68% +$117K ﹤0.01% 1744
2022
Q3 		$201K Buy
7,611
+6,500
+585% +$193K ﹤0.01% 1812
2022
Q2 		$27K Sell
1,111
-15,507
-93% -$387K ﹤0.01% 2415
2022
Q1 		$551K Sell
16,618
-9,940
-37% -$276K ﹤0.01% 2179
2021
Q4 		$868K Buy
+26,558
New +$904K ﹤0.01% 2025

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Allspring Global Investments's RGNX Position: Q3 2024 in Review

Allspring Global Investments sold out of Regenxbio (RGNX) in Q3 2024, closing a stake of 325 shares — an estimated $3.8K sold.

Allspring Global Investments first reported a position in RGNX in Q4 2021 and held it in 10 quarters. The position peaked at $868K in Q4 2021. 186 funds tracked by Wall St. Rank hold RGNX as of Q3 2024.

  • Allspring Global Investments reported no remaining Regenxbio position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 325 Regenxbio shares in Q3 2024, an estimated $3.8K.
  • Allspring Global Investments first reported a position in Regenxbio in Q4 2021 and held it in 10 quarters.
  • Allspring Global Investments's Regenxbio position peaked at $868K in Q4 2021.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.